SRPT FY 2016 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+332.6% YoY

Gross Profit

$5M97.6% margin

Operating Income

-$267M-4920.3% margin

Net Income

-$267M-4930.2% margin

EPS (Diluted)

$-5.49

Cash Flow

Operating Cash Flow

-$246M

Free Cash Flow

-$253M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$424M

Total Liabilities

$87M

Stockholders' Equity

$337M

Cash & Equivalents

$122M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$1M	+332.6%
Gross Profit	$5M	-$145M	+103.7%
Operating Income	-$267M	-$220M	-21.1%
Net Income	-$267M	-$220M	-21.5%